(R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate

更新时间:2024-02-05 08:55:15

(R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate结构式
(R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate结构式
委托求购
常用名 (R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate 英文名 (R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate
CAS号 1093397-71-7 分子量 426.58800
密度 N/A 沸点 N/A
分子式 C27H38O4 熔点 N/A
MSDS N/A 闪点 N/A

 名称

英文名 (R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate

 物理化学性质

分子式 C27H38O4
分子量 426.58800
精确质量 426.27700
PSA 52.60000
LogP 5.78250

 合成线路

~%

(R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate结构式

(R,E)-methyl 4-...

1093397-71-7

文献:KYTHERA BIOPHARMACEUTICALS, INC.; MORIARTY, Robert M.; PRASAD, Achampeta Rathan; REID, John Gregory; SWARINGEN Jr., Roy A. Patent:   WO2011/75701 A2, 2011 ;

~%

(R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate结构式

(R,E)-methyl 4-...

1093397-71-7

文献:KYTHERA BIOPHARMACEUTICALS, INC.; MORIARTY, Robert M.; PRASAD, Achampeta Rathan; REID, John Gregory; SWARINGEN Jr., Roy A. Patent:   WO2011/75701 A2, 2011 ;

~%

(R,E)-methyl 4-((3R,5R,8S,10S,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate结构式

(R,E)-methyl 4-...

1093397-71-7

文献:KYTHERA BIOPHARMACEUTICALS, INC.; MORIARTY, Robert M.; PRASAD, Achampeta Rathan; REID, John Gregory; SWARINGEN Jr., Roy A. Patent:   WO2011/75701 A2, 2011 ;